| BREA |
Brera Holdings PLC |
Class B Ordinary Shares, $0.005 nominal value per share |
11.54% |
$5.39M |
|
7.28M |
|
ARK Investment Management LLC |
Sep 30, 2025 |
| NTLA |
Intellia Therapeutics, Inc. |
Common Stock |
11.1% |
$206M |
|
11.9M |
|
ARK Investment Management LLC |
Sep 30, 2025 |
| CRSP |
CRISPR Therapeutics AG |
Common Stock |
10.76% |
$634M |
-$24.5M |
9.79M |
-3.72% |
ARK Investment Management LLC |
Sep 30, 2025 |
| TWST |
Twist Bioscience Corp |
Common Stock |
10.7% |
$231M |
$37.1M |
6.38M |
+19.1% |
ARK Investment Management LLC |
Feb 28, 2025 |
| TXG |
10x Genomics, Inc. |
Class A Common Stock, $0.00001 par value per share |
10.39% |
$139M |
-$11.2M |
11.9M |
-7.46% |
ARK Investment Management LLC |
Sep 30, 2025 |
| BEAM |
Beam Therapeutics Inc. |
Common Stock |
10.35% |
$190M |
$70.8M |
10.4M |
+59.4% |
ARK Investment Management LLC |
Jul 31, 2025 |
| PACB |
Pacific Biosciences of California, Inc. |
Common Stock |
10.3% |
$39.6M |
|
30.9M |
|
ARK Investment Management LLC |
Sep 30, 2025 |
| CERS |
CERUS CORP |
Common Stock |
10.05% |
$25.2M |
-$2.11M |
19.2M |
-7.72% |
ARK Investment Management LLC |
Jun 30, 2025 |
| PD |
PagerDuty, Inc. |
Common Stock |
9.47% |
$146M |
-$19.6M |
8.83M |
-11.9% |
ARK Investment Management LLC |
Sep 30, 2025 |
| ABSI |
Absci Corp |
Common Stock |
8.6% |
$33.1M |
$8.12M |
11M |
+32.5% |
ARK Investment Management LLC |
Mar 31, 2025 |
| RXRX |
Recursion Pharmaceuticals, Inc. |
Class A Common Stock |
8.47% |
$186M |
|
32.3M |
|
ARK Investment Management LLC |
Dec 31, 2024 |
| PSNL |
Personalis, Inc. |
Common Stock |
8.14% |
$21.8M |
$1.25M |
7.19M |
+6.09% |
ARK Investment Management LLC |
Mar 31, 2025 |
| SRTA |
Strata Critical Medical, Inc. |
Common Stock |
7.52% |
$32.4M |
|
6.4M |
|
ARK Investment Management LLC |
Sep 30, 2025 |
| ARCT |
Arcturus Therapeutics Holdings Inc. |
Common Stock |
6.32% |
$22.1M |
|
1.72M |
|
ARK Investment Management LLC |
Jun 30, 2025 |
| IRDM |
Iridium Communications Inc. |
Common Stock |
6.12% |
$113M |
|
6.49M |
|
ARK Investment Management LLC |
Sep 30, 2025 |
| VCYT |
VERACYTE, INC. |
Common Stock |
5.68% |
$153M |
$43.3M |
4.47M |
+39.3% |
ARK Investment Management LLC |
Sep 30, 2025 |
| ROKU |
ROKU, INC |
Class A Common Stock, $0.0001 par value per share |
5.64% |
$736M |
-$129M |
7.35M |
-14.9% |
ARK Investment Management LLC |
Sep 30, 2025 |
| MASS |
908 Devices Inc. |
Common Stock |
5.41% |
$17.1M |
-$7.31M |
1.95M |
-29.9% |
ARK Investment Management LLC |
Sep 30, 2025 |
| QSI |
Quantum-Si Inc |
Common Stock |
4.77% |
$11.8M |
-$1.37M |
7.81M |
-10.4% |
ARK Investment Management LLC |
May 31, 2025 |
| RPTX |
Repare Therapeutics Inc. |
Common Shares, no par value |
4.7% |
$2M |
|
2M |
|
ARK Investment Management LLC |
Dec 31, 2024 |
| BFLY |
Butterfly Network, Inc. |
Common Stock |
4.66% |
$20.6M |
|
8.68M |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| ACHR |
Archer Aviation Inc. |
Class A Common Stock, par value $0.0001 |
4.64% |
$284M |
-$10.9M |
25.4M |
-3.69% |
ARK Investment Management LLC |
May 31, 2025 |
| CDNA |
CareDx, Inc. |
Common Stock |
4.49% |
$44.4M |
-$10.7M |
2.41M |
-19.4% |
ARK Investment Management LLC |
Dec 31, 2024 |
| PATH |
UiPath, Inc. |
Class A common stock, par value $0.00001 per share |
4.48% |
$228M |
|
20.9M |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| VUZI |
Vuzix Corp |
Common Stock |
3.77% |
$416 |
|
249 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| KIND |
Nextdoor Holdings, Inc. |
Class A common stock, $0.0001 par value per share |
3.67% |
$9.93M |
|
6.9M |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common Stock |
2.9% |
$40.9M |
-$15.5M |
4.4M |
-27.5% |
ARK Investment Management LLC |
May 31, 2025 |
| KDK |
Kodiak AI, Inc. |
Common Stock, par value $0.0001 per share |
1.24% |
$15.4M |
$9.13M |
2.26M |
+145% |
ARK Investment Management LLC |
Oct 31, 2025 |
| MKFG |
Markforged Holding Corp |
Common Stock, $0.0001 par value per share |
0% |
$0.20 |
|
1 |
-100% |
ARK Investment Management LLC |
Dec 31, 2024 |
| TWOU |
2U, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| VLD |
Velo3D, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| ACCD |
Accolade, Inc. |
Common Stock |
0% |
$0 |
-$37.8M |
0 |
-100% |
ARK Investment Management LLC |
Mar 31, 2025 |
| DNA |
Ginkgo Bioworks Holdings, Inc. |
Class A Common Stock, par value $0.0001 |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| TDOC |
Teladoc Health, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| NVTAQ |
Invitae Corp |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| SLGC |
SomaLogic, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| NRIX |
Nurix Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |
| VERV |
Verve Therapeutics, Inc. |
Common Stock |
0% |
$0 |
|
0 |
|
ARK Investment Management LLC |
Sep 30, 2024 |